Bicara Therapeutics
Cambridge
About Bicara Therapeutics
Bicara Therapeutics is a clinical-stage biotechnology startup focused on developing dual-action biologics. The business is developing bifunctional antibodies that are designed to deliver an immunomodulatory payload directly to the tumor microenvironment, assisting cancer patients in increasing immune cell activity and potentially providing long-term efficacy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $463.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nasdaq:BCAX
- Website: bicara.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bicara-therapeutics-82207 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.